Pretzel Therapeutics

Pretzel Therapeutics

Edit info

  • Founded: 2021
  • Location: Waltham, MA
  • Employee range: 11 - 50
  • Clinical stage: RD
  • Therapy area: Mitochondrial dysfunction diseases
  • Drug types: GEN, RAR, ONC, NEU
  • Lead product: Undisclosed
  • Funding: $72.5M A Sep 2022
  • Investors: ARCH Venture Partners, Mubadala Capital, HealthCap, Cambridge Innovation Capital, Cambridge Enterprise, Angelini Ventures, GV, Invus, Eir Ventures, GU Ventures, Karolinska Institutet Holding


pretzeltx.com

linkedin.com

job board


About:

Pretzel Therapeutics is leading the way for a new era of life-changing medicines for mitochondrial diseases. Mitochondrial diseases arise when there is an cellular imbalance of mutated, dysfunctional mitochondria to healthy mitochondria. Pretzel is designing a portfolio of programs to upregulate the healthy levels of mitochondrial DNA (mtDNA) with their compounds showing a dose-dependent increase in mtDNA production. By applying their technology to various organs and tissues, Pretzel has the potential for multi-organ therapeutic benefit for a wide range of mitochondrial diseases and other diseases associated with aging and neurodegeneration.

Jobs:

Post a job


© 2024 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com